The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.
NYS Entity Status
NYS Filing Date
AUGUST 05, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - CNS PHARMACEUTICALS, INC.
AROUND THE WEB
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
- Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
By STEPHANIE CLIFFORD - Thursday Jun 22, 2017
The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.
- Insurers Battle Families Over Costly Drug for Fatal Disease
By KATIE THOMAS - Thursday Jun 22, 2017
The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
By Ben Fidler - Tuesday Jun 13, 2017
A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]